Bluejay Diagnostics, Inc. (BJDX)
NASDAQ·Healthcare·Medical - Devices
$1.88
-1.05%
Mkt Cap $816.37K
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 6, 2026 | — | — | — | — | -$2.37 | — | — | — |
| Q4 2025 Nov 7, 2025 | — | — | — | — | -$4.04 | — | — | — |
| Q3 2025 Aug 7, 2025 | — | — | — | — | -$1.41 | — | — | — |
| Q2 2025 May 13, 2025 | — | — | — | — | -$3.37 | — | — | — |
| Q1 2025 Mar 31, 2025 | — | $216.09K | — | -$144.00 | -$112.37 | +21.97% | — | — |
| Q4 2024 Nov 7, 2024 | — | — | — | -$144.00 | -$8.00 | +94.44% | — | — |
| Q3 2024 Aug 14, 2024 | — | — | — | -$144.00 | -$256.00 | -77.78% | — | — |
| Q2 2024 May 15, 2024 | — | — | — | -$1152.00 | -$396.00 | +65.63% | — | — |
| Q1 2024 Mar 28, 2024 | — | $1.45M | — | -$272.00 | -$712.00 | -161.76% | — | — |
| Q4 2023 Nov 9, 2023 | — | — | — | -$328.00 | -$832.00 | -153.66% | — | — |
| Q3 2023 Aug 14, 2023 | — | — | — | -$600.00 | -$1100.00 | -83.33% | — | — |
| Q2 2023 May 10, 2023 | $809.00K | — | — | -$480.00 | -$960.00 | -100.00% | — | — |
| Q1 2023 Mar 20, 2023 | — | — | — | $320.00 | -$960.00 | -400.00% | — | — |
| Q4 2022 Nov 9, 2022 | — | — | — | -$640.00 | -$1120.00 | -75.00% | — | — |
| Q3 2022 Jul 26, 2022 | — | $249.04K | — | -$640.00 | -$800.00 | -25.00% | — | — |
| Q2 2022 Apr 20, 2022 | — | — | — | -$880.00 | -$800.00 | +9.09% | — | — |
| Q1 2022 Mar 10, 2022 | — | — | — | — | -$720.00 | — | — | — |
| Q4 2021 Dec 16, 2021 | — | — | — | — | -$39.16 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | — | — | — | -$24.38 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$9.87 | — | — | — |